Drug intelligence / Profile preview

Maiwei Dihuang Pills

Development stage
Unknown
Lead developer
Lanzhou Foci
Modality
Small Molecules
Administration
Oral
01

Overview

Maiwei Dihuang Pills is a traditional Chinese medicine (TCM) formulation developed and manufactured by Lanzhou Foci Pharmaceutical. It is an expansion of the classical Liuwei Dihuang formula, supplemented with *Ophiopogon japonicus* and *Schisandra chinensis* to enhance its therapeutic effects on the lungs and kidneys. The complete formulation consists of eight herbal ingredients: *Rehmannia glutinosa*, *Cornus officinalis*, *Dioscorea opposita* (yam), *Poria cocos*, *Alisma orientalis*, *Paeonia suffruticosa* (peony bark), *Ophiopogon japonicus*, and *Schisandra chinensis*. In TCM theory, it is primarily used to nourish kidney and lung Yin and to 'receive qi.' It is clinically indicated for conditions associated with Yin deficiency, such as chronic dry cough, night sweats, dizziness, tinnitus, and symptoms associated with menopause.

Brand names
Min ShanPlum Flower
Other names
麦味地黄丸Mai Wei Di Huang WanEight Flavor Rehmannia Pills
02

Targets

EGR1 (Early growth response protein 1)VEGFA (Vascular endothelial growth factor A)BMP4 (Bone morphogenetic protein 2)

Beyond the preview

Go deeper on Maiwei Dihuang Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maiwei Dihuang Pills.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call